Clinical Trials Browser

Suspended × Lymphoma, B-Cell × Clear all

NCT04746131 2022-09-26

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

Phase 1 Suspended

Lymphoma, B-Cell

NCT04697290 2022-02-14

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Phase EARLY_PHASE1 Suspended

Lymphoma, B-Cell